UBS Maintains Neutral on Lineage, Raises Price Target to $45

Benzinga Newsdesk www.benzinga.com Neutral 56.5%

Neg 0% Neu 56.5% Pos 0%

UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and raises the price target from $35 to $45.